arrow
J

Juhani Knuuti

University of Turku
H指数:128
被引数:22.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Epicardial adipose tissue volumes improve prediction of myocardial infarction in women on top of SCORE2, CACS and plaque burden: Long-term follow-up of 25,000 individuals

心外膜脂肪组织体积在SCORE2、CACS和斑块负荷基础上提高了女性心肌梗死的预测能力:25,000例个体的长期随访

2026-10-290
OAAI
Radiation burden of contemporary diagnostic pathways for chronic coronary syndromes: an ancillary analysis of the international EURECA Imaging Registry

当代慢性冠状动脉综合征诊断路径的辐射负担:国际EURECA影像登记研究的附属分析

2026-09-280
PRE
Improved Assessment of Coronary Artery Disease in Obese Subjects with Flurpiridaz-18F PET Myocardial Perfusion Imaging: A Prespecified Subgroup Analysis of the AURORA Phase 3 Study

肥胖受试者中应用Flurpiridaz-18F PET心肌灌注成像改善冠状动脉疾病评估:AURORA III期研究的预先指定亚组分析

2026-05-120
PRE
Changes in hemoglobin levels and cardiometabolic health in adults with metabolic syndrome – a secondary outcome analysis of a six-month randomized controlled trial

代谢综合征成人患者血红蛋白水平与心代谢健康的变化——一项为期六个月的随机对照试验的次要结局分析

2026-02-280
OA
Effects of Reducing Sedentary Behaviour on Cardiac Structure and Function at Rest and During Exercise: A 6-Month Randomized Controlled Trial

减少静坐行为对静息状态及运动期间心脏结构与功能的影响:一项为期6个月的随机对照试验

2026-01-012
OA
The Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Trial―IMAGE HF Project 1A

缺血性心力衰竭中的替代成像模式(AIMI-HF)试验——IMAGE HF项目1A

2025-11-010
OA
Phase III Prospective Multicenter Study Assessing Diagnostic Efficacy of a18F-labeled Myocardial Perfusion Tracer [18F]SYN2. SAFER 3.

III期前瞻性多中心研究评估a18F标记的心肌灌注示踪剂[18F]SYN2的诊断效能。SAFER 3。

2025-08-280
PRE